On Monday, for the second time in as many business days, Illumina (NASDAQ: ILMN) stock took it on the chin because of an ...

Illumina (NASDAQ:ILMN – Get Free Report) was downgraded by investment analysts at Barclays from an “equal weight” rating to ...

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 7.5% in the morning session after Barclays downgraded ...

Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday after Morgan Stanley lowered their price target on the stock from $150.00 to ...

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning session after the company reported fourth-quarter ...

Piper Sandler analyst David Westenberg raised the firm’s price target on Illumina (ILMN) to $190 from $185 following quarterly results. The ...

Illumina, Inc. ILMN reported better-than-expected results for its fourth quarter on Thursday. The company posted quarterly ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

Citi analyst Patrick Donnelly lowered the firm’s price target on Illumina (ILMN) to $130 from $165 and keeps a Neutral rating on the shares ...